Qiu-Zhong Pan (Qiuzhong Pan)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Genome Wide Identification

Machine Learning

Top Venues

Molecular cancer therapeutics

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Nan Fang, Bing Liu, Qiu-Zhong Pan, Tingting Gong, Meixiao Zhan, Jingjing Zhao, Qi-Jing Wang, Yan Tang, Yong-Qiang Li, Jia He, Tong Xiang, Fengze Sun, Li-Gong Lu, Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular cancer therapeutics 23 (8) (2024)
Yuanyuan Chen, Muping Di, Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, Dijun Ouyang, Jieying Yang, Hao Chen, Yan Wang, Desheng Weng, Qiu-Zhong Pan, Tong Xiang, Jian-Chuan Xia
Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene 43 (28) (2024)
Yuanyuan Chen, Muping Di, Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, Dijun Ouyang, Jieying Yang, Hao Chen, Yan Wang, Desheng Weng, Qiu-Zhong Pan, Tong Xiang, Jian-Chuan Xia
Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene (2024)
Yuanyuan Chen, Muping Di, Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, Dijun Ouyang, Jieying Yang, Hao Chen, Yan Wang, Desheng Weng, Qiu-Zhong Pan, Tong Xiang, Jian-Chuan Xia
Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. Oncogene 43 (28) (2024)
Nan Fang, Bing Liu, Qiu-Zhong Pan, Tingting Gong, Meixiao Zhan, Jingjing Zhao, Qi-Jing Wang, Yan Tang, Yong-Qiang Li, Jia He, Tong Xiang, Fengze Sun, Li-Gong Lu, Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular cancer therapeutics (2024)
Xi-Zhi Wen, Qiu-Zhong Pan, Bu-Shu Xu, Wei Xiao, De-Sheng Weng, Jing-Jing Zhao, Hai-Rong Xu, Zhen Huang, Xiao-Hui Niu, Xing Zhang
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma. Cancer chemotherapy and pharmacology 89 (2) (2022)